Eam Investors, LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Eam Investors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$23.12 - $29.91 $2.47 Million - $3.19 Million	-106,777 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$14.69 - $42.57 $1.57 Million - $4.55 Million	106,777 New	106,777 $2.74 Million
Q2 2019 Aug 14, 2019	SELL	$18.44 - $30.89 $439,425 - $736,108	-23,830 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$16.51 - $31.1 $298,269 - $561,852	-18,066 Reduced 43.12%	23,830 $682,000
Q3 2018 Nov 08, 2018	BUY	$8.0 - $22.11 $335,168 - $926,320	41,896 New	41,896 $926,000

135

52M

551K

98K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $240M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.